Unlike AD, in which studies have generally reported higher plasma Aβ42, lower CSF Aβ42, and higher plasma and CSF phosphorylated tau levels in individuals with AD compared to cognitively healthy individuals, the literature in schizophrenia is mixed with both similar and differing levels reported in PWS. This evidence concerns the gene MAPT and Alzheimer disease.